Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Rani Therapeutics stock surged 200% after securing a $1 billion partnership with Chugai and raising $60 million in funding.

A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

The percentage of patients with a GLP-1 RA prescription before metabolic and bariatric surgery increased from 5.6% to 26.9% from 2020 to 2024.

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...

Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have ...

Novo Nordisk NVO shares fell roughly 4% in pre-market trading today after U.S. President Donald Trump signaled potential ...

You may notice changes to your sexual performance and love life if you take glucagon-like peptide-1 (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepound, Mounjaro). These ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...